medigraphic.com
ISSN 1029-3035 (Electronic)

2011, Number S2

<< Back Next >>

Mediciego 2011; 17 (S2)

Congenital toxoplasmosis. A case presentation

Fernández RF, Meizoso VAI, Cervantes MM, Carrasco FDL, Alvarado BKB, Rodríguez RLA

Language: Spanish
References: 15
Page:
PDF size: 93.64 Kb.


ABSTRACT

The congenital toxoplasmosis happens when the woman is primoinfected during gestation. The acute infection in pregnant women is not demonstrated in around 90% of the cases. A case of 33,3 weeks new born appears, 1966 grams weight, Apgar 9/9, with maternal antecedents of infertility and presented retroplacental hematoma of 50% that took it to the pregnancy interruption by high route of urgency, with delayed prenatal diagnosis of “hydrocephalus” that is stated at birth; also it observes manifold clinical findings such as: prominent forehead, open anterior and posterior fontanelles, as well as opened sutures, cephalic circumference: 31.5 cm, short palpebral fissures and hepatosplenomegaly of ± 3 cm, all this make suspect a congenital infection group TORCH, reason why ultrasonografic study and TAC is carried out to him as well as extractions of blood, the diagnosis of congenital toxoplasmosis in the Tropical Medicine Institute “Pedro Kourí” is stated. It is derived to the Neurosurgery Service from Camagüey where it passes away to the 9 months of life by infection of the central nervous system.


REFERENCES

  1. Fabre E, Bartha JL, de Miguel JR, Rodríguez Alarcón J, Dulín E, Farrán I, González A, González Nieves L. Grupo de consenso sobre toxoplasmosis. Prog Obstet Ginecol. 2003; 46(7):319-32.

  2. Camargo ME. Algunos aspectos atuais do diagnóstico de laboratório da toxoplasmose. An Acad Nac Med. 1995; 155(4):236-9.

  3. Ferguson W, Mayne PD, Lennon B, Butler K, Cafferkey M. Susceptibility of pregnant women to toxoplasma infection--potential benefits for newborn screening. Ir Med J [Internet]. 2008 [citado 15 Nov 2011]; 101(7):220-1. Disponible en: http://preview.ncbi.nlm.nih.gov/pubmed/18807815#

  4. Pinon JM, Chemla C, Villena I, Foudrinier F, Aubert D, Puygauthier-Toubas D, et al. Early neonatal diagnosis of congenital toxoplasmosis: value of comparative enzyme-linked immunofiltration assay immunological profiles and anti-Toxoplasma gondii immunoglobulin M (IgM) or IgA immunocapture and implications for postnatal therapeutic strategies. J Clin Microbiol. 1996; 34(3):579-83.

  5. Stepick-Biek P, Thulliez P, Araujo FG, Remington JS. IgA antibodies for diagnosis of acute congenital and acquired toxoplasmosis. J Infect Dis. 1990; 162:270-3.

  6. Pinon JM, Toubas D, Marx C, Mougeot A, Bonnin A, Bonhomme M, et al. Detection of specific immunoglobulin E in patients with toxoplasmosis. J Clin Microbiol. 1990; 28(8):1739-43.

  7. Boyer KM, Holfels E, Roizen N, Swisher C, Mack D, Remington J, Withers S, Meier P, McLeod R; Toxoplasmosis Study Group. Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: Implications for prenatal management and screening. Am J Obstet Gynecol [Internet]. 2005 [citado 15 Nov 2011]; 192(2):564- 71. Disponible en: http://preview.ncbi.nlm.nih.gov/pubmed/15696004#

  8. Lopes-Mori FM, Mitsuka-Breganó R, Capobiango JD, Inoue IT, Reiche EM, Morimoto HK, et al. Programs for control of congenital toxoplasmosis. Rev Assoc Med Bras [Internet]. 2011 [citado 15 Nov 2011]; 57(5):594-599. Disponible en: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104- 42302011000500021&lng=en&nrm=iso&tlng=en

  9. Amendoeira MRR, Costa T da, Spalding SM. Toxoplasma gondii Nicolle & Manceaux, 1909 (Apicomplexa: Sarcocystidae) e a Toxoplasmose. Rev Souza Marques. 1999; 1:15-29.

  10. Fricker Hidalgo A, Pelloux H, Muet F, Racinet C, Bost M, Goullier-Fleuret A, et al. Prenatal diagnosis of congenital toxoplasmosis: comparative value of fetal blood and amniotic fluid using serological techniques and cultures. Prenat Diag. 1997; 17:831-5.

  11. Amendoeira MRR. Toxoplasmosis research aproach. Mem Inst Oswaldo Cruz. 1997; 92(suppl I):38-9.

  12. García A. Aspectos morfológicos feto-placentários na infecção congênita pelo toxoplasma gondii. An Acad Nac Med. 1995; 155(4):229-31.

  13. Ferguson W, Mayne PD, Cafferkey M, Butler K. Lack of awareness of risk factors for primary toxoplasmosis in pregnancy. Ir J Med Sci [Internet]. 2011 [citado 15 Nov 2011]; 180(4):807-11. Disponible en: http://preview.ncbi.nlm.nih.gov/pubmed/21660651#

  14. Gómez Marín JE, de la Torre A, Angel Muller E, Rubio J, Arenas J, Osorio E, et al. First Colombian multicentric newborn screening for congenital toxoplasmosis. PLoS Negl Trop Dis [Internet]. 2011 [citado 23 Sep 2011]; 5(5): [aprox. 9 p.]. Disponible en: http://dx.plos.org/10.1371/journal.pntd.0001195

  15. López A, Dietz VJ, Wilson M, Navin TR, Jones JL. Preventing congenital toxoplasmosis. MMWR Recomm Rep [Internet]. 2000 [citado 17 Mar 2011]; 49(RR-2):59-68. Disponible en: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr4902a5.htm




2020     |     www.medigraphic.com